The future of inflammatory bowel disease management: combining progress in trial design with advances in targeted therapy.

Anti-tumour necrosis factor antagonists have appreciably improved patient outcomes in Crohn's disease, shifting the goals of treatment from control of symptoms to clinical remission (Crohn's disease activity index <150) combined with mucosal healing - the new concept of 'deep r...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों: Travis, S, Feagan, BG, Rutgeerts, P, van Deventer, S
स्वरूप: Journal article
भाषा:English
प्रकाशित: 2012

समान संसाधन